[1]文雪莲,热米拉·热扎克,唐月红.2010—2020年新疆宫颈癌经济负担及筛查覆盖率的影响研究[J].卫生经济研究,2024,41(05):32-35,40.
　WEN Xuelian,Remila REZHAKE,TANG Yuehong.Study on the Economic Burden of Cervical Cancer and the Impact of Screening Coverage in Xinjiang from 2010 to 2020[J].Journal Press of Health Economics Research,2024,41(05):32-35,40.
点击复制

2010—2020年新疆宫颈癌经济负担及筛查覆盖率的影响研究
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
41
期数:
2024年05期
页码:
32-35,40
栏目:
专题研究
出版日期:
2024-04-23

文章信息/Info

Title:
Study on the Economic Burden of Cervical Cancer and the Impact of Screening Coverage in Xinjiang from 2010 to 2020
作者:
文雪莲1; 热米拉·热扎克2; 唐月红2
1.新疆医科大学公共卫生学院，新疆 乌鲁木齐 830000
2.新疆医科大学附属肿瘤医院，新疆 乌鲁木齐 830000
Author(s):
WEN Xuelian;  Remila REZHAKE;  TANG Yuehong
School of Public Health, Xinjiang Medical University, Urumqi Xinjiang 830000, China
关键词:
宫颈癌; 疾病经济负担; 住院费用; 筛查覆盖率; Markov模型
Keywords:
cervical cancer;  economic burden of disease;  hospitalization costs;  screening coverage;  Markov model
分类号:
R19
文献标志码:
A
摘要:
目的：探讨新疆宫颈癌患者住院费用情况，评估和预测提高筛查覆盖率对宫颈癌防治的影响，对宫颈癌防治策略提出建议。方法：利用2010—2020年10 256例新疆宫颈癌住院患者病案首页信息，分析其住院费用及影响因素，利用Markov模型预测筛查覆盖率对宫颈癌防治的影响。结果：近年来新疆宫颈癌患者住院费用持续上涨，次均住院费用从27 946.83元增长至51 260.00元，影响住院费用的因素主要有是否进行HPV检测、治疗方式、病理分期、住院时间以及年龄，提高宫颈癌筛查覆盖率可降低发病率、死亡率。结论：新疆宫颈癌患者直接医疗经济负担较重，筛查是防治宫颈癌的有效手段，应继续加强宫颈癌健康知识宣教，提高疫苗接种率和筛查覆盖率，促进早诊早治措施的推广。
Abstract:
Objective To explore the hospitalization costs of cervical cancer patients in Xinjiang, to assess and predict the impact of increasing screening coverage on cervical cancer prevention and treatment, and to make recommendations on cervical cancer prevention and treatment strategies. Methods Using the homepage information of 10 256 inpatients with cervical cancer in Xinjiang from 2010 to 2020, the hospitalization costs and influencing factors were analyzed. The impact of screening coverage on cervical cancer prevention and treatment was predicted by using the Markov model. Results In recent years, the hospitalization costs of cervical cancer patients in Xinjiang has continued to rise, with the average hospitalization cost per visit increasing from 27 946.83 yuan to 51 260.00 yuan. Factors affecting hospitalization cost mainly included whether or not to undergo HPV testing, treatment method, pathological stage, hospitalization time and age. The increase of cervical cancer screening coverage could reduce morbidity and mortality. Conclusion Cervical cancer patients in Xinjiang have a heavy direct medical economic burden. Screening is an effective means to prevent and treat cervical cancer. It is necessary to continue to strengthen the health knowledge education of cervical cancer, improve the vaccination rate and screening coverage, and promote early diagnosis and treatment measures.

参考文献/References:

[1] Arbyn M,Weiderpass E,Bruni L,et al.Estimates of incidence and mortality of cervical cancer in 2018:a worldwide analysis[J].The Lancet Global Health,2020,8(02):e191-e203.
[2] Farley J,Ervil M,Lam F,et al.Global cancer observatory:cancer today[R].Lyon,France:international agency for research on cancer,2020.
[3] Ama Buskwofie,Gizelka David-West,Camille A Clare.A review of cervical cancer:incidence and disparities[J].Journal of the National Medical Association,2020,112(02):229-232.
[4] 贺妮楠，邹卓如，张云博，等.中国人乳头瘤病毒感染相关疾病经济负担：系统文献回顾和综合分析[J].中华疾病控制杂志，2023，27（03）：345-351.
[5] 陶思源，赵方辉，杨春霞，等.子宫颈癌及癌前病变患者直接经济负担及其影响因素研究[J].中华预防医学杂志，2018，52（12）：1281-1286.
[6] 妥静，程豪政，吴肇滏，等.2020年新疆生产建设兵团第八师女性HPV感染亚型分析[J].中国艾滋病性病，2023，29（06）：719-720.
[7] 李海涛，王岩，沈谷群，等.宫颈癌与癌前病变患者的经济负担研究[J].预防医学，2022，34（04）：350-356.
[8] 袁克兵，张培英，杨猛，等.2005-2020年山东省滕州市宫颈癌流行特征及经济负担研究[J].中国肿瘤，2023，32（01）：20-26.
[9] 彭介入，陶思源，温莹，等.中国城镇地区子宫颈癌筛查的卫生经济学评价[J].中华肿瘤杂志，2019，41（02）：154-160.
[10] 李国荣，乔友林，唐晓，等.Markov模型在评价宫颈癌筛查绩效分析中的应用[J].中国卫生统计，2010，27（01）：17-20.
[11] 李严，周大创，李洪超.如何在中国开展药物经济学评价的系统评价[J].世界临床药物，2023，44（05）：429-436.
[12] 丁贤彬，吕晓燕，焦艳，等.2006-2021年重庆市女性宫颈癌发病率长期趋势分析[J].现代肿瘤医学，2023，31（12）：2323-2329.
[13] 左鹏，李小平.妇科恶性肿瘤基因检测、靶向治疗及免疫治疗现状[J].中国临床医生杂志，2023，51（03）：271-275.
[14] Matsuo K,Purushotham S,Jiang B,et al.Survival outcome prediction in cervical cancer:cox models vs deep-learning model[J].Am J ObstetGynecol,2019 Apr,220(04):381.e1-381.e14.
[15] 孙昊，党建红，高京海，等.复方醋酸染色联合阴道镜法在宫颈癌前病变筛查中的价值研究[J].海军医学杂志，2022，4（07）：754-757.
[16] 王岩，王豆，昆阿依木·叶尔江，等.自我采样HPV检测作为新疆卫生资源匮乏地区宫颈癌初筛替代手段的筛查效果[J].现代妇产科进展，2023，32（02）：90-94.
[17] 陈猛，夏昌发，刘冰，等.中国子宫颈低级别鳞状上皮内病变患者经济负担分析[J].中国肿瘤，2021，30（11）：827-833.
[18] Abramowitz L,Lacau Saint Guily J,Moyal-Barracco M,et al. Epidemiological and economic burden of potentially hpv-related cancers in france[J].PLoS One,2018,13(09):e0202564.
[19] Singh M P,Chauhan A S,Rai B,et al.Cost of treatment for cervical cancer in India[J].Asian Pacific Journal of Cancer Prevention: APJCP,2020,21(09):2639.
[20] Johnson CA,James D,Marzan A,et al.Cervical cancer: an overview of pathophysiology and management[J].Semin Oncol Nurs,2019,35(02):166-174.
[21] 张根，覃青连，苏玉璐，等.2018-2021年广西南宁市6839例宫颈癌患者住院费用分析[J].右江医学，2022，50（05）：375-379.
[22] Pilleron S,Cabasag C J,Ferlay J,et al.Cervical cancer burden in latinamerica and the caribbean:where are we?[J].International Journal of Cancer,2020,147(06):1638-1648. [23] 何玥，吴玉梅，王建东，等.老年女性子宫颈病变筛查及异常管理中国专家共识（2023年版）[J].中国实用妇科与产科杂志，2023，39（05）：531-536.
[24] Clark M,Jembere N,Wang L,et al.Survival of older women with cervical cancer based on screening history[J].J Low Genit Tract Dis, 2021,25(01):9-14.
[25] 任悦.临床路径在医院医疗质量管理中的应用效果[J].医学信息，2021，34（22）：182-184.

相似文献/References:

[1]于保荣,许 晴,刘 卓,等.新发传染病经济负担的方法学研究[J].卫生经济研究,2017,(07):25.
[2]王晓茹,李银山,王 瑶,等.宁南地区新农合大病患者医疗费用负担分析[J].卫生经济研究,2017,(10):30.
[3]于保荣,冯映雪,江陈庆,等.肿瘤疾病经济负担与健康保险政策研究[J].卫生经济研究,2018,(04):14.
[4]冷 瑶,李燕喃,邓 晶.我国中老年糖尿病患者的疾病经济负担分析[J].卫生经济研究,2018,(10):47.
　LENG Yao,LI Yan-nan,DENG Jing.Analysis of the Economic Burden of Diseases in Middle-aged and Elderly Patients with Diabetes in China[J].Journal Press of Health Economics Research,2018,(05):47.
[5]明星宇,杨 练,孙 群,等.四川省糖尿病疾病经济负担及影响因素分析[J].卫生经济研究,2019,(01):29.
　MING Xing-yu,YANG Lian,SUN Qun,et al.The Disease Economic Burden and Influence of Diabetes in Sichuan Province[J].Journal Press of Health Economics Research,2019,(05):29.
[6]向 芳,李 胜,郝 莲,等.2003—2017年中国女性宫颈癌死亡趋势分析——基于年龄—时期—队列模型[J].卫生经济研究,2020,(05):23.
　XIANG Fang,LI Sheng,HAO Lian,et al.Analysis on Chinese Women's Cervical Cancer Death Trends from 2003 to 2017——Based on Age-Period-Cohort Model[J].Journal Press of Health Economics Research,2020,(05):23.
[7]董 辉,汤质如,严 训,等.安徽省恶性肿瘤治疗费用分析——基于“卫生费用核算体系2011”[J].卫生经济研究,2021,38(2):58.
　DONG Hui,TANG Zhi-ru,YAN Xun,et al.Analysis on Malignant Tumor Treatment Cost in Anhui Province——Based on the SHA 2011[J].Journal Press of Health Economics Research,2021,38(05):58.
[8]黎倩欣,周尚成,陈飘飘,等.深圳市糖尿病疾病经济负担研究[J].卫生经济研究,2021,38(3):63.
　LI Qian-xin,ZHOU Shang-cheng,CHEN Piao-piao,et al.Study on the Economic Burden of Diabetic Diseases in Shenzhen[J].Journal Press of Health Economics Research,2021,38(05):63.
[9]王佳卉,马增香.多囊卵巢综合征及其并发症的直接经济负担研究进展[J].卫生经济研究,2022,39(3):24.
　WANG Jia-hui,MA Zeng-xiang.Research Progress on Direct Economic Burden of Polycystic Ovary Syndrome and Its Complications[J].Journal Press of Health Economics Research,2022,39(05):24.
[10]李福明,夏 宇,魏 艳,等.晚期非小细胞肺癌初治患者的直接非医疗成本分析[J].卫生经济研究,2022,39(10):58.
　LI Fuming,XIA Yu,WEI Yan,et al.Analysis of Direct Non-medical Cost of Newly Treated Advanced Non-small Cell Lung Cancer Patients[J].Journal Press of Health Economics Research,2022,39(05):58.

更新日期/Last Update: 2024-04-23